175 related articles for article (PubMed ID: 16243305)
1. Peripheral cholinergic disturbances in Alzheimer's disease.
Rakonczay Z; Horváth Z; Juhász A; Kálmán J
Chem Biol Interact; 2005 Dec; 157-158():233-8. PubMed ID: 16243305
[TBL] [Abstract][Full Text] [Related]
2. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
[TBL] [Abstract][Full Text] [Related]
3. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T
Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
5. Molecular forms of acetylcholinesterases in Alzheimer's disease.
Younkin SG; Goodridge B; Katz J; Lockett G; Nafziger D; Usiak MF; Younkin LH
Fed Proc; 1986 Dec; 45(13):2982-8. PubMed ID: 2430839
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.
Kamruecha W; Chansirikarnjana S; Nimkulrat E; Udommongkol C; Wongmek W; Thangnipon W
Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):793-7. PubMed ID: 17121308
[TBL] [Abstract][Full Text] [Related]
7. Decrease in membrane-bound G4 form of acetylcholinesterase in postmortem Alzheimer brain.
Schegg KM; Nielsen S; Zweig RM; Peacock JH
Prog Clin Biol Res; 1989; 317():437-52. PubMed ID: 2602428
[TBL] [Abstract][Full Text] [Related]
8. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk.
Combarros O; Riancho JA; Infante J; Sañudo C; Llorca J; Zarrabeitia MT; Berciano J
Dement Geriatr Cogn Disord; 2005; 20(2-3):153-7. PubMed ID: 16020944
[TBL] [Abstract][Full Text] [Related]
9. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
Arendt T; Brückner MK; Lange M; Bigl V
Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
[TBL] [Abstract][Full Text] [Related]
10. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
Beyer K; Lao JI; Latorre P; Ariza A
Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
[TBL] [Abstract][Full Text] [Related]
11. Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease.
Eggers C; Herholz K; Kalbe E; Heiss WD
Neurosci Lett; 2006 Nov; 408(1):46-50. PubMed ID: 16996687
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
13. No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.
Maetzler W; Keller S; Michelis J; Koehler N; Stransky E; Becker C; Schulte C; Melms A; Gasser T; Berg D
Neurobiol Dis; 2009 Aug; 35(2):296-301. PubMed ID: 19481150
[TBL] [Abstract][Full Text] [Related]
14. Acetyl- and butyrylcholinesterase activities in the rat retina and retinal pigment epithelium.
Sánchez-Chávez G; Vidal CJ; Salceda R
J Neurosci Res; 1995 Aug; 41(5):655-62. PubMed ID: 7563246
[TBL] [Abstract][Full Text] [Related]
15. Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients.
Kálmán J; Juhász A; Rakonczay Z; Abrahám G; Zana M; Boda K; Farkas T; Penke B; Janka Z
Life Sci; 2004 Jul; 75(10):1195-204. PubMed ID: 15219807
[TBL] [Abstract][Full Text] [Related]
16. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
[TBL] [Abstract][Full Text] [Related]
17. Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population.
Simão-Silva DP; Bertolucci PH; de Labio RW; Payão SL; Furtado-Alle L; Souza RL
Chem Biol Interact; 2013 Mar; 203(1):358-60. PubMed ID: 23022600
[TBL] [Abstract][Full Text] [Related]
18. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
[TBL] [Abstract][Full Text] [Related]
19. Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer's disease in a Southern Brazilian population.
Bono GF; Simão-Silva DP; Batistela MS; Josviak ND; Dias PF; Nascimento GA; Souza RL; Piovezan MR; Souza RK; Furtado-Alle L
Neurochem Int; 2015 Feb; 81():57-62. PubMed ID: 25624079
[TBL] [Abstract][Full Text] [Related]
20. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system.
Atack JR; Perry EK; Bonham JR; Candy JM; Perry RH
J Neurochem; 1986 Jul; 47(1):263-77. PubMed ID: 3711902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
